GB201219873D0 - Diverticulitis treatment - Google Patents

Diverticulitis treatment

Info

Publication number
GB201219873D0
GB201219873D0 GBGB1219873.5A GB201219873A GB201219873D0 GB 201219873 D0 GB201219873 D0 GB 201219873D0 GB 201219873 A GB201219873 A GB 201219873A GB 201219873 D0 GB201219873 D0 GB 201219873D0
Authority
GB
United Kingdom
Prior art keywords
diverticulitis
treatment
diverticulitis treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1219873.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Multigerm UK Enterprises Ltd
Original Assignee
Multigerm UK Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multigerm UK Enterprises Ltd filed Critical Multigerm UK Enterprises Ltd
Priority to GBGB1219873.5A priority Critical patent/GB201219873D0/en
Publication of GB201219873D0 publication Critical patent/GB201219873D0/en
Priority to PCT/GB2013/052879 priority patent/WO2014068338A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
GBGB1219873.5A 2012-11-05 2012-11-05 Diverticulitis treatment Ceased GB201219873D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1219873.5A GB201219873D0 (en) 2012-11-05 2012-11-05 Diverticulitis treatment
PCT/GB2013/052879 WO2014068338A1 (en) 2012-11-05 2013-11-04 Diverticulitis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1219873.5A GB201219873D0 (en) 2012-11-05 2012-11-05 Diverticulitis treatment

Publications (1)

Publication Number Publication Date
GB201219873D0 true GB201219873D0 (en) 2012-12-19

Family

ID=47429166

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1219873.5A Ceased GB201219873D0 (en) 2012-11-05 2012-11-05 Diverticulitis treatment

Country Status (2)

Country Link
GB (1) GB201219873D0 (en)
WO (1) WO2014068338A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131467A1 (en) 2013-09-06 2015-03-07 Sofar Spa USE OF A COMPOSITION INCLUDING MICRO-ORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTIRRIC ACID, FOLIC ACID OR NIACINE ACID AND / OR TO REDUCE THE INTESTINAL PRODUCTION OF SUCCINIC ACID
MA39710A (en) 2014-04-23 2015-10-29 Sofar Spa Topical composition for use in the treatment of inflammatory bowel disease
MA45327A (en) 2016-05-13 2019-03-20 Sofar Spa USE OF PROBIOTICS TO IMPROVE PROTEIN ABSORPTION
MA45288A (en) 2016-06-08 2019-04-17 Sofar Spa New medical use of probiotics
KR101938865B1 (en) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 Composition for preventing or treating bone disease, obesity and lipid-related metabolic disease
IT201600122724A1 (en) 2016-12-02 2018-06-02 Sofar Spa EXOPOLYSACCHARIDES AND USES THEREOF
IT201600127498A1 (en) * 2016-12-16 2018-06-16 Sofar Spa PROBIOTICS FOR USE IN DIVERTICULOSIS AND DIVERTICULAR DISEASE
EP3723775A4 (en) 2017-12-15 2022-04-13 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
WO2021062250A1 (en) * 2019-09-25 2021-04-01 Tall Goods, Llc Methods for producing probiotics fortified avian eggs and egg products and formulations thereof
GB201915144D0 (en) * 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2418431A (en) * 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
US20150087616A1 (en) * 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use

Also Published As

Publication number Publication date
WO2014068338A1 (en) 2014-05-08

Similar Documents

Publication Publication Date Title
HK1211475A1 (en) Combination therapy
GB2513074B (en) Treated apertures
EP2906208A4 (en) Therapeutic treatment
GB201219873D0 (en) Diverticulitis treatment
EP2862620A4 (en) Discharge-gas treatment system
GB201221329D0 (en) Dermatitis treatment
GB201217439D0 (en) Combination therapy
ZA201408855B (en) Flocculation treatment agent
GB201502225D0 (en) Formation treatment system
EP2777576A4 (en) Treatment system
EP2803328A4 (en) Treatment system
EP2789306A4 (en) Treatment system
GB201207305D0 (en) Therapy
HK1210426A1 (en) Combination therapy
GB201204981D0 (en) Pre-harvest treatment
ZA201308117B (en) Avian-based treatment
EP2804853A4 (en) Therapeutic uses
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment
GB201212604D0 (en) New treatment
GB201221326D0 (en) Novel treatments
GB201205449D0 (en) Treatment process
AU2012900513A0 (en) Avian-Based Treatment
GB201212457D0 (en) Smart-road-smart-smart-vehicle synergy
GB201211543D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)